Severe acute respiratory virus syndrome 2 (SARS-CoV-2) has led to a worldwide pandemic.
Early studies in solid organ transplant (SOT) recipients suggested a wide variety of …

Background Immunosuppression and comorbidities increase the risk of severe coronavirus
disease-2019 (COVID-19) in solid organ transplant (SOT) recipients. The outcomes of …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …

Background A significant increased risk of complications and mortality in
immunocompromised patients affected by COVID-19 has been described. However, the …

Data describing outcomes of solid organ transplant (SOT) recipients with coronavirus
disease 2019 (COVID‐19) are variable, and the association between SOT status and …

The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,
hospitalization and death, and the effects of SARS-CoV-2 vaccines in solid organ transplant …

Patients with chronic liver disease (CLD) with or without cirrhosis remain at risk of
developing hepatic decompensation when infected with viral or bacterial pathogens. The …

Background. Solid organ transplant recipients (SOTr) are at increased risk for severe
disease from coronavirus disease 2019 (COVID-19) compared with non-SOTr. Methods. We …

Abstract The coronavirus disease 2019 (COVID-19) represents a global health and
economic challenge. Hepatic injuries have been approved to be associated with severe …

Abstract Although SARS-CoV-2, responsible for COVID-19, is primarily a respiratory
infection, a broad spectrum of cardiac, pulmonary, neurologic, and metabolic complications …